News Image

BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data

Provided By GlobeNewswire

Last update: Nov 13, 2024

– Blinded preliminary data demonstrate a positive trend and clear signal in Primary and Secondary endpoints –

– Patient reported efficacy outcomes show a material decrease in pain and increase in function –

Read more at globenewswire.com

BIORESTORATIVE THERAPIES INC

NASDAQ:BRTX (12/12/2025, 8:16:51 PM)

After market: 1.1001 -0.01 (-0.89%)

1.11

+0.01 (+0.91%)



Find more stocks in the Stock Screener

Follow ChartMill for more